{
  "docId": "019de071-25c2-72af-a047-b47d3e86c276",
  "docSlug": "cf4915d9030a007285d7f2ca06f3bce1",
  "documentTitle": "Graphite Bio | IPO Presentation Deck | 50 slides",
  "authorId": "graphite-bio",
  "authorName": "Graphite Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 50,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Slide 10 of an investor presentation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-25c2-72af-a047-b47d3e86c276/10",
  "deckHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276",
  "deckJsonHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276.json",
  "deckAnchorHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb35534f-9681-4f40-9c9d-e4db1f8aa503",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.41,
        "y": 0.65
      },
      "kind": "list",
      "text": "Gene replacement: XSCID; Targeted gene insertion: Gaucher; Discovery programs: prevalent diseases",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37ebfd39-790d-49bb-9620-14d1cd2caa3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.23,
        "y": 0.65
      },
      "kind": "list",
      "text": "Accepted IND; First-in-industry approach aiming to correct sickle mutation and restore normal adult hemoglobin",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c9493df-2132-4414-a6b7-1420a00490ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "list",
      "text": "Leveraging high-efficiency targeted gene integration; Preparing to initiate Ph1/2 sickle cell disease (SCD) program; Broadening HSC applications via pipeline programs and discovery; Expand patient eligibility and non-HSC applications; Deeply-experienced team",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9dcc2b81-aae5-4fde-9f61-6a117221d3fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "list",
      "text": "Correct, replace, insert genes; Gene integration above curative ranges; Continuous platform innovation to improve efficiency",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2b41833-f416-4bfa-9d15-02c79960c4c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.59,
        "y": 0.65
      },
      "kind": "list",
      "text": "Pursue non-genotoxic HSC-targeted conditioning; Non-HSC cell types; In vivo applications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "caf502ea-5036-4ae7-a408-db455d0b3829",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.77,
        "y": 0.65
      },
      "kind": "list",
      "text": "Founded by Stanford gene editing pioneers; Seasoned management team; Leading investors & board",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e71054e9-aeb1-4698-b67f-0dad9757b213",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Graphite Bio: a clinical-stage gene editing company poised to translate a platform into therapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "863ae88c-b9b3-4c64-9e85-625a2ad0ee36",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "8b4fcbde-abe7-4ac1-b838-9f0f26a11d4b",
      "evidence": "The slide is titled 'executive_summary' and contains a list of bullet points summarizing the company's status and plans.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}